CAFERGOT (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the CAFERGOT drug offered from KAISER FOUNDATION HOSPITALS. This Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
| NON-PROPRIETARY NAME: | Ergotamine Tartrate and Caffeine |
| SUBSTANCE NAME: | ERGOTAMINE TARTRATE; CAFFEINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-04-21 |
| END MARKETING DATE: | 0000-00-00 |
CAFERGOT HUMAN PRESCRIPTION DRUG Details:
| Item Description | CAFERGOT from KAISER FOUNDATION HOSPITALS |
| LABELER NAME: | KAISER FOUNDATION HOSPITALS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1; 100(mg/1; mg/1) |
| START MARKETING DATE: | 2011-04-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0179-0089_eb4f1418-2342-4174-a448-1335dea53deb |
| PRODUCT NDC: | 0179-0089 |
| APPLICATION NUMBER: | ANDA084294 |
Other ERGOTAMINE TARTRATE; CAFFEINE Pharmaceutical Manufacturers / Labelers:
